Device type · JGS
Electrode, Ion Specific, Sodium
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
JGS
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
19
510(k), De Novo and PMA
Adverse event reports
110
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Electrode, Ion Specific, Sodium
- Product code
- JGS
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1665
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for JGS
Latest FDA decisions
The 8 newest of 19 since 2015.
- ABL90 FLEX PLUS System510(k)
K252475 · Decided May 1, 2026 · 267 days after receipt
Device type: Electrode, Ion Specific, Sodium (JGS) · Laboratory Medicine & Pathology
K230275 · Decided Oct 27, 2023 · 268 days after receipt
Device type: Electrode, Ion Specific, Sodium (JGS) · Laboratory Medicine & Pathology
Siemens Healthcare Diagnostics, Inc.
K222438 · Decided Jul 25, 2023 · 347 days after receipt
Device type: Electrode, Ion Specific, Sodium (JGS) · Laboratory Medicine & Pathology
16 more FDA decisions with a free account
Reports received
110
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
110
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 12 | 0 | 0 | 0 |
| Jan 24 | 5 | 0 | 0 | 0 |
| Feb 24 | 10 | 0 | 0 | 0 |
| Mar 24 | 18 | 0 | 0 | 0 |
| Apr 24 | 11 | 0 | 0 | 0 |
| May 24 | 10 | 0 | 0 | 0 |
| Jun 24 | 3 | 0 | 0 | 0 |
| Jul 24 | 10 | 0 | 0 | 0 |
| Aug 24 | 7 | 0 | 0 | 0 |
| Sep 24 | 4 | 0 | 0 | 0 |
| Oct 24 | 5 | 0 | 0 | 0 |
| Nov 24 | 6 | 0 | 0 | 0 |
| Dec 24 | 7 | 0 | 0 | 0 |
| Jan 25 | 4 | 0 | 0 | 0 |
| Feb 25 | 10 | 0 | 0 | 0 |
| Mar 25 | 2 | 0 | 0 | 0 |
| Apr 25 | 5 | 0 | 0 | 0 |
| May 25 | 5 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 5 | 0 | 0 | 0 |
| Aug 25 | 4 | 0 | 0 | 0 |
| Sep 25 | 10 | 0 | 0 | 0 |
| Oct 25 | 4 | 0 | 0 | 0 |
| Nov 25 | 7 | 0 | 0 | 0 |
| Dec 25 | 8 | 0 | 0 | 0 |
| Jan 26 | 3 | 0 | 0 | 0 |
| Feb 26 | 3 | 0 | 0 | 0 |
| Mar 26 | 9 | 0 | 0 | 0 |
| Apr 26 | 9 | 0 | 0 | 0 |
| May 26 | 7 | 0 | 0 | 0 |
| Jun 26 | 25 | 0 | 0 | 0 |
| Jul 26 | 26 | 0 | 0 | 0 |
| Aug 26 | 3 | 0 | 0 | 0 |
| Sep 26 | 4 | 0 | 0 | 0 |
| Oct 26 | 6 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Abbott13
3 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- High Test Results73
- Low Test Results20
- Non Reproducible Results20
5 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions104
- Facial Paralysis2
- Hyperkalemia2
5 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- epoc BGEM BUN Test Card [25pk]. Material Number: 10736515.Open, Classified
Siemens Healthcare Diagnostics Inc
Z-2272-2025 · Started Jul 7, 2025 · Posted by FDA Aug 5, 2025
Reason given: Siemens Healthcare Diagnostics Inc. has confirmed that a negative sodium bias may exist in some epoc test card lots. All other analytes are performing as intended. The observed average bias for sodium was -4.4 mmol/L. The maximum bias observed was -14 mmol/L, which occurred at a higher sodium concentration around 150...
Cause as FDA categorized it: Under Investigation by firm
- RAPIDPOINT 500e Blood Gas SystemOpen, Classified
Siemens Healthcare Diagnostics Inc
Z-0422-2024 · Started Sep 26, 2023 · Posted by FDA Dec 1, 2023
Reason given: There are potential drug interferences from Perhexiline Maleate or Atomoxetine Hydrochloride that may cause falsely elevated sodium results reported on the RAPIDPoint 500 and RAPIDPoint 500e Blood Gas Systems. The erroneous sodium levels with positive bias may lead to unrecognized hyponatremia and/or the inappropriate...
Cause as FDA categorized it: Under Investigation by firm
- RAPIDPOINT 500 Blood Gas SystemOpen, Classified
Siemens Healthcare Diagnostics Inc
Z-0423-2024 · Started Sep 26, 2023 · Posted by FDA Dec 1, 2023
Reason given: There are potential drug interferences from Perhexiline Maleate or Atomoxetine Hydrochloride that may cause falsely elevated sodium results reported on the RAPIDPoint 500 and RAPIDPoint 500e Blood Gas Systems. The erroneous sodium levels with positive bias may lead to unrecognized hyponatremia and/or the inappropriate...
Cause as FDA categorized it: Under Investigation by firm
45 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.